| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 40 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 40 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 40 |
| 3 | DOXORUBICIN | 34 |
| 4 | ETOPOSIDE | 28 |
| 5 | TACROLIMUS | 27 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 27 |
| 7 | TACROLIMUS OINTMENT 0.1% | 27 |
| 8 | PREDNISONE | 26 |
| 9 | CYTARABINE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 3 | 0.0035 |
| 1 | DAUNORUBICIN HYDROCHLORIDE | 5 | 0.0030 |
| 2 | THIOGUANINE | 6 | 0.0028 |
| 3 | DACTINOMYCIN | 6 | 0.0027 |
| 4 | ALDESLEUKIN | 3 | 0.0024 |
| 5 | CARMUSTINE | 10 | 0.0021 |
| 6 | DACARBAZINE | 12 | 0.0016 |
| 7 | BLEOMYCIN SULFATE | 16 | 0.0015 |
| 8 | IFOSFAMIDE FOR INJECTION | 15 | 0.0007 |
| 9 | MERCAPTOPURINE | 8 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 52 |
| 1 | Corticosteroid [EPC] | 46 |
| 2 | Topoisomerase Inhibitor [EPC] | 28 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 23 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 5 | Purine Antimetabolite [EPC] | 11 |
| 6 | Kinase Inhibitor [EPC] | 8 |
| 7 | Retinoid [EPC] | 8 |
| 8 | Janus Kinase Inhibitor [EPC] | 7 |
| 9 | Platinum-based Drug [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 1 | Actinomycin [EPC] | 6 | 0.0027 |
| 2 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 3 | Topoisomerase Inhibitor [EPC] | 28 | 0.0004 |
| 4 | Alkylating Drug [EPC] | 52 | 0.0002 |
| 5 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 6 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 23 | 0.0001 |
| 8 | Pyridone [EPC] | 2 | 0.0000 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |